Skip to main content
Contact Info
Tim Dudgeon
Life science software and data management expert

Virtual screening of SARS-Cov-2 Main protease fragment screening hits. 

Presenting author: Tim Dudgeon

An X-ray structure based fragment screening program was set up at Diamond Light Source in the  early days of the COVID-19 pandemic and has progressed rapidly (1). A number of covalent and  non-covalent fragment hits were quickly identified. We have been performing virtual screening  workflows of compounds derived from the non-covalent hits (2, 3) which has identified 10’s of  thousands of potential compounds, far too many to purchase and test, and effective prioritisation of  those candidates is a far from trivial process requiring predictions of potency, 3D visualisation,  considerations of how tractable the compound is for follow up chemistry and possible ADMET  liabilities that might surface downstream. 

We welcome the involvement of the OpenTox community in providing insights into how ADMET  predictions can be incorporated into this process at scale. Access to all virtual screening data is  available.